Intervention

Caspofungin

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsNCT02856178 · 2017-04-20

WITHDRAWN

Effect of Weight and/or Obesity on Caspofungin Drug ConcentrationsNCT01062165 · 2010-02-01

COMPLETED

Prophylaxis of Fungal Invasive Infections in LeukemiaNCT00501098 · 2007-01-01

COMPLETED

Common conditions

Acute Myeloid Leukemia1 Fungal Infection1 Invasive Pulmonary Aspergillosis1 Obesity1 Pulmonary Aspergillosis - Invasive1

Leading sponsors

F2G Ltd 1 Northern Italy Leukemia Group 1 Texas Tech University Health Sciences Center 1

Trial status mix

COMPLETED2

WITHDRAWN1

Phase mix

PHASE22

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.